Who
Troy Cox
Director
Company insider
Files Form 4 as: Director, MapLight Therapeutics; Director, Standard BioTools; Director, SOPHiA GENETICS SA; Director, Zymeworks; Executive Chair, SomaLogic; Director, Zymeworks; President and CEO, Foundation Medicine.
In numbers
- Trades disclosed
- 61
- Buys
- 2
- Sells
- 5
- Bought
- $646K
- Sold
- $3.3M
- Companies
- 7
- Companies where not an officer
- 5
- First trade
- 6 Feb 2017
- Last trade
- 28 Jul 2026
- Last filed
- 28 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Jul 2026filed 28 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Bought | $149K15,620 at $9.52 | filing |
| 28 Jul 2026filed 28 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Bought | $149K15,620 at $9.52 | filing |
| 23 Jun 2026filed 25 Jun 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Code A | —7,864 at $0.00 | filing |
| 23 Jun 2026filed 25 Jun 2026 | MPLT MapLight Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,804 at $0.00 | filing |
| 23 Jun 2026filed 25 Jun 2026 | MPLT MapLight Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,804 at $0.00 | filing |
| 23 Jun 2026filed 25 Jun 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Code A | —7,864 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code A | —99,116 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | LAB Standard BioToolsoption or derivative · Life-science tools | SEC FORM 4 Code A | —175,923 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | LAB Standard BioToolsoption or derivative · Life-science tools | SEC FORM 4 Code A | —175,923 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code A | —99,116 at $0.00 | filing |
| 18 Jun 2026filed 22 Jun 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Code A | $108K19,724 at $5.46 | filing |
| 18 Jun 2026filed 22 Jun 2026 | SOPH SOPHiA GENETICS SAoption or derivative · Payments & Processors | SEC FORM 4 Code A | $157K28,818 at $5.46 | filing |
| 18 Jun 2026filed 22 Jun 2026 | SOPH SOPHiA GENETICS SAoption or derivative · Payments & Processors | SEC FORM 4 Code A | $157K28,818 at $5.46 | filing |
| 18 Jun 2026filed 22 Jun 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Code A | $108K19,724 at $5.46 | filing |
| 26 Feb 2026filed 2 Mar 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code A | $67K57,264 at $1.17 | filing |
| 26 Feb 2026filed 2 Mar 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code A | $67K57,264 at $1.17 | filing |
| 20 Jun 2025filed 24 Jun 2025 | LAB Standard BioToolsoption or derivative · Life-science tools | SEC FORM 4 Code A | —125,660 at $0.00 | filing |
| 20 Jun 2025filed 24 Jun 2025 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code A | —94,592 at $0.00 | filing |
| 28 Feb 2025filed 4 Mar 2025 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code A | $67K62,910 at $1.07 | filing |
| 10 Dec 2024filed 12 Dec 2024 | ZYME Zymeworksoption or derivative · Biotechnology | SEC FORM 4 Code A | —31,000 at $0.00 | filing |
News
MapLight Therapeutics Celebrates Co-Founder Dr. Karl Deisseroth on Receipt of 2026 Nobel Prize in Physiology or Medicine for the Development of OptogeneticsMPLT · manilatimes.net · 6 Oct 2026
0 headlines in the last 90 days name Troy Cox; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.